Daiichi Sankyo and Merck’s BLA for ifinatamab deruxtecan granted priority review in US for adult patients with ES-SCLC who experienced disease progression on or after platinum-based chemotherapy ...
ICMR invites industry to fast-track dual typhoid vaccine for India’s urgent public health needs: Shardul Nautiyal, Mumbai Tuesday, April 14, 2026, 08:00 Hrs [IST] In a significa ...
Panel asks DoP to ensure budget allocations for bulk drug parks to be in tandem with implementation capacity: Gireesh Babu, New Delhi Tuesday, April 14, 2026, 08:00 Hrs [IST] Taki ...
Ministry of health launches mobile app to strengthen clinical workflow of CHOs: Our Bureau, New Delhi Tuesday, April 14, 2026, 09:00 Hrs [IST] In a step towards strengthening prim ...
Maharashtra FDA recruitment drive gains momentum as process for 154 DIs’ appointment advances: Shardul Nautiyal, Mumbai ...
AKCDA treasurer demands resignation of general secretary Antony Tharyan over counterfeit medicine scandal: Peethaambaran Kunnathoor, Chennai Tuesday, April 14, 2026, 08:00 Hrs [IS ...
Outdated curriculum, poor college inspections mar India’s pharmacy education: Dr BG Nagavi: Nandita Vijayasimha, Bengaluru Tuesday, April 14, 2026, 08:00 Hrs [IST] India’s pha ...
Jassar Dental Medical Education Health Foundation’s Rs. 302.18 crore ratings reaffirmed by Informerics: Our Bureau, Bengaluru Monday, April 13, 2026, 17:25 Hrs [IST] Jassar Dent ...
Nutrify Today sees AI is transforming nutraceuticals from the lab to shelf in just a few months: Our Bureau, Bengaluru Monday, April 13, 2026, 15:15 Hrs [IST] Nutrify Today sees a ...
SRMIST to host International Physiotherapy Conference & International Hand Conclave 2026 from April 16 to 18 at Kattankulathur campus, Chennai: Our Bureau, Mumbai Monday, April 13 ...
Galmed announces the breakthrough development of a brain penetrating new formulation of its SCD1 inhibitor, Aramchol: Ramat-Gan, Israel Monday, April 13, 2026, 17:00 Hrs [IST] Gal ...
Kainova begins patient dosing in European expansion of its DOMISOL phase I/II trial of DT-7012, a Treg-depleting anti-CCR8 antibody in patients with advanced solid tumours: Montre ...